Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheja

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Rheumatology|February 14, 2009
Renal function is mostly preserved in patients with systemic sclerosisA Scheja, I Bartosik, D M Wuttge, et al.
Clinical and Experimental Rheumatology|January 1, 1986
Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteersA Scheja, A Forsgren, K Ohlsson, et al.
The Journal of Rheumatology|April 1, 1994
Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosisA Scheja, J Eskilsson, A Akesson, et al.
Annals of the Rheumatic Diseases|October 1, 1993
Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung complianceA Scheja, A Akesson, P Wollmer, et al.
Arthritis and Rheumatism|May 1, 1994
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamideA Akesson, A Scheja, A Lundin, et al.
Annals of the Rheumatic Diseases|February 7, 2002
Correlation between plasma concentrations of calcitonin gene related peptide and pulmonary pressure in patients with systemic sclerosisI Bartosik, J Eskilsson, R Ekman, et al.
Scandinavian Journal of Rheumatology|April 12, 2014
Vascular events are risk factors for anal incontinence in systemic sclerosis: a study of morphology and functional properties measured by anal endosonography and manometryI Bartosik, K Andréasson, M Starck, et al.
Journal of Internal Medicine|January 6, 2011
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosisK Andréasson, A Scheja, T Saxne, et al.
Scandinavian Journal of Rheumatology|August 15, 2017
Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosisG Sandqvist, P Wollmer, A Scheja, et al.
Rheumatology (Oxford, England)|March 22, 2003
The association of antinuclear antibodies with organ involvement and survival in systemic sclerosisR Hesselstrand, A Scheja, G Q Shen, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Rheumatology|February 14, 2009
Renal function is mostly preserved in patients with systemic sclerosisA Scheja, I Bartosik, D M Wuttge, et al.
Clinical and Experimental Rheumatology|January 1, 1986
Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteersA Scheja, A Forsgren, K Ohlsson, et al.
The Journal of Rheumatology|April 1, 1994
Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosisA Scheja, J Eskilsson, A Akesson, et al.
Annals of the Rheumatic Diseases|October 1, 1993
Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung complianceA Scheja, A Akesson, P Wollmer, et al.
Arthritis and Rheumatism|May 1, 1994
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamideA Akesson, A Scheja, A Lundin, et al.
Annals of the Rheumatic Diseases|February 7, 2002
Correlation between plasma concentrations of calcitonin gene related peptide and pulmonary pressure in patients with systemic sclerosisI Bartosik, J Eskilsson, R Ekman, et al.
Scandinavian Journal of Rheumatology|April 12, 2014
Vascular events are risk factors for anal incontinence in systemic sclerosis: a study of morphology and functional properties measured by anal endosonography and manometryI Bartosik, K Andréasson, M Starck, et al.
Journal of Internal Medicine|January 6, 2011
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosisK Andréasson, A Scheja, T Saxne, et al.
Scandinavian Journal of Rheumatology|August 15, 2017
Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosisG Sandqvist, P Wollmer, A Scheja, et al.
Rheumatology (Oxford, England)|March 22, 2003
The association of antinuclear antibodies with organ involvement and survival in systemic sclerosisR Hesselstrand, A Scheja, G Q Shen, et al.
Pageof 5